Femalegra
Femalegra improves woman’s sexuality, increases sensitivity to stimulation, allows to reach an intense sexual satisfaction.
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.00 | $50.00 (0%) | 🛒 Add to cart |
| 20 | $3.00 | $100.00 $60.00 (40%) | 🛒 Add to cart |
| 30 | $2.33 | $150.00 $70.00 (53%) | 🛒 Add to cart |
| 60 | $1.67 | $300.00 $100.00 (67%) | 🛒 Add to cart |
| 90 | $1.44 | $450.00 $130.00 (71%) | 🛒 Add to cart |
| 120 | $1.33 | $600.00 $160.00 (73%) | 🛒 Add to cart |
| 180 | $1.22 | $900.00 $220.00 (76%) | 🛒 Add to cart |
| 270 | $1.00 | $1350.00 $270.00 (80%) | 🛒 Add to cart |
| 360 | $0.85
Best per pill | $1800.00 $305.00 (83%) | 🛒 Add to cart |
Similar products
More info:
Abhigra: Advanced Treatment for Erectile Dysfunction
Abhigra is a clinically validated pharmaceutical agent designed to address erectile dysfunction (ED) with precision and reliability. Formulated with sildenafil citrate as its active ingredient, it functions by enhancing blood flow to the penile tissues, facilitating sustainable and satisfactory erections. This medication is intended for adult males experiencing difficulties in achieving or maintaining an erection sufficient for sexual activity. Supported by extensive research and adherence to stringent manufacturing standards, Abhigra offers a trusted solution for improving sexual health and quality of life.
Alprostadil: Restoring Natural Erections for Erectile Dysfunction
Alprostadil is a synthetic prostaglandin E1 analog used primarily in the treatment of erectile dysfunction (ED). As a vasodilator, it works by relaxing smooth muscle tissue and dilating cavernosal arteries, thereby increasing blood flow into the penis to facilitate an erection. This medication is available in several administration forms, including intracavernosal injection, intraurethral pellet, and topical cream, offering flexibility based on patient preference and clinical suitability. It represents a well-established, effective second-line therapy for men who do not respond to or cannot use oral phosphodiesterase type 5 inhibitors.
Androxal: Clinically Validated Testosterone Restoration Therapy
Androxal (enclomiphene citrate) represents a significant advancement in the treatment of male hypogonadism, specifically for men with secondary hypogonadism. Unlike traditional testosterone replacement therapies (TRT) which often suppress natural hormone production and can impair fertility, Androxal works through a novel mechanism of action. It stimulates the hypothalamic-pituitary-gonadal (HPG) axis to promote the body’s own endogenous testosterone production. This profile provides a comprehensive, evidence-based overview of its specifications, clinical application, and safety data for healthcare professionals.
Apcalis SX Oral Jelly: Fast-Acting Erectile Dysfunction Relief
Apcalis SX Oral Jelly is a specialized phosphodiesterase type 5 (PDE5) inhibitor formulated for the treatment of erectile dysfunction. It contains Tadalafil as its active pharmaceutical ingredient, delivered in a convenient, palatable oral jelly format for rapid absorption and predictable pharmacokinetics. This formulation is designed to offer a reliable therapeutic option with an onset of action typically within 15–30 minutes, supporting spontaneity and reducing planning-related anxiety. It is intended for adult male use under appropriate medical supervision.
Aurogra: Effective Treatment for Erectile Dysfunction
Aurogra is a prescription medication specifically formulated to address erectile dysfunction (ED) in adult men. It contains Sildenafil Citrate, a potent phosphodiesterase type 5 (PDE5) inhibitor that enhances blood flow to the penile tissues, facilitating the achievement and maintenance of an erection sufficient for sexual activity. This medication is clinically proven, requires sexual stimulation for efficacy, and should be used under appropriate medical supervision to ensure safety and optimal therapeutic outcomes.
Avana: Advanced PDE5 Inhibition for Confident Erection Control
Avana (avanafil) is a next-generation phosphodiesterase type 5 (PDE5) inhibitor engineered for rapid onset and sustained efficacy in the treatment of erectile dysfunction. Its highly selective mechanism targets the cavernosal smooth muscle with precision, facilitating robust nitric oxide-mediated vasodilation while minimizing off-target effects. Clinically validated for reliability and patient satisfaction, Avana represents a refined therapeutic option for men seeking predictable erectile response with favorable tolerability. This agent combines pharmacokinetic advantages with a well-characterized safety profile, making it a cornerstone in modern sexual medicine protocols.
Betahistine: Effective Vertigo and Meniere's Disease Symptom Control
Betahistine is a histamine analogue specifically indicated for the management of vestibular disorders, most notably vertigo associated with Meniere’s disease. It functions as a histamine H1-receptor agonist and H3-receptor antagonist, improving microvascular circulation in the inner ear and reducing endolymphatic pressure. This pharmacological profile makes it a cornerstone therapy for patients experiencing debilitating episodes of dizziness, tinnitus, and hearing loss. Clinical use is supported by guidelines for symptomatic control and improvement in quality of life.
Cardura: Effective Blood Pressure and BPH Symptom Control
Cardura (doxazosin mesylate) is an alpha-1 adrenergic blocker prescription medication clinically proven to manage two significant conditions: hypertension (high blood pressure) and the symptoms of benign prostatic hyperplasia (BPH). By selectively relaxing smooth muscle in blood vessel walls and the prostate gland, it facilitates improved blood flow and easier urination. This dual-action mechanism offers a targeted therapeutic approach for patients requiring management of these often co-occurring conditions, providing a foundation for enhanced cardiovascular and urological health under proper medical supervision.
Caverta: Effective Treatment for Erectile Dysfunction
Caverta is a prescription medication specifically formulated to address erectile dysfunction (ED) in adult men. It contains the active ingredient Sildenafil Citrate, a well-established phosphodiesterase type 5 (PDE5) inhibitor that enhances blood flow to the penile tissues. This facilitates the achievement and maintenance of an erection sufficient for satisfactory sexual activity when combined with sexual stimulation. Clinically tested and trusted by healthcare professionals globally, Caverta offers a reliable therapeutic option for men seeking to restore sexual function and improve quality of life.